NCT03043170

Brief Summary

Background to the research Patients present to Emergency Departments (ED) with a spectrum of illness, many of which are life- threatening. The body has the ability to compensate in the early stages when things go wrong so that on the surface patients do not appear as sick as they really are. Under-diagnosis of severity of illness leads to under-treatment, unnecessary mortality, and unnecessary hospital costs. Earlier diagnosis and consequent treatment will result in prudent healthcare, cost-benefit and better patient outcomes. Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power and peripheral pressures gives vital clues to the hidden seriousness of illness and is a guide to better management. Few EDs in the world assess such haemodynamics. After evaluating a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if applied across EDs in Wales. However, before we can do that we need to strengthen our understanding of haemodynamics, and of relevant protocols and non-invasive devices that help us to acquire such information. Study Design After ethics and institutional approval is obtained from we will conduct a prospective, single-centre, cohort study on 354 adult patients with possible shock associated with an acute illness or injury who present to the Emergency Department of the University Hospital of Wales, and follow them up for 7 days. 354 is a credible number to confirm that the strategy works. Written consent will be obtained either from the patient or a relative wherever possible but a waiver of consent apply to patients who, because of confusion, unconsciousness or severe disability, may be unable to give consent. In these cases, consent will first be sought from a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a relative as soon as practically possible. What you hope to discover We expect to discover that:

  • Uscom variables predict 7-day survival and ICU admission
  • Uscom variables improve the detection and classification of shock
  • The LiPS definition can be improved.
  • The objective definition is better than doctors experience
  • Patients have a good experience and are satisfied with care

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
361

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 3, 2017

Completed
26 days until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

January 5, 2021

Status Verified

January 1, 2021

Enrollment Period

1.5 years

First QC Date

February 2, 2017

Last Update Submit

January 4, 2021

Conditions

Keywords

AdultsEmergency DepartmentHaemodynamicsResuscitationShockUscom

Outcome Measures

Primary Outcomes (1)

  • Composite of ICCU/all cause mortality

    Number of patients with admission to either ICU, or CCU, or death from any cause

    7 days

Secondary Outcomes (5)

  • In-hospital mortality

    28 days

  • 28-day mortality

    28 days

  • Admission to ICCU

    7 days

  • ED shock

    Within 4 hours of ED arrival

  • Types of ED Shock

    Within 4 hours of ED arrival

Other Outcomes (1)

  • Feasibility variables

    4 hours

Interventions

a device for assessing haemodynamics continuously and non-invasively using Doppler wave ultrasound

Also known as: USCOM®; USCOM Pty Ltd, NSW, Australia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive adult patients presenting to the ED of University Hospital of Wales (UHW) with a NEWS\>3, requiring a trolley, and during research study periods

You may qualify if:

  • Adult patients aged ≥18 years
  • a NEWS≥3,
  • requiring a trolley

You may not qualify if:

  • \<18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiff University

Cardiff, S Glamorgan, CF14 4XN, United Kingdom

Location

MeSH Terms

Conditions

ShockEmergencies

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Officials

  • Timothy H Rainer, MD

    Professor of Emergency Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2017

First Posted

February 3, 2017

Study Start

March 1, 2017

Primary Completion

August 31, 2018

Study Completion

August 31, 2018

Last Updated

January 5, 2021

Record last verified: 2021-01

Locations